Abstracts Are Now LiveView in the online program, via RPTH or on the ISTH Academy.
Late-breaking abstract submission closed on June 7th, 2019. Regular abstract submission closed on February 4, 2019. Abstract Guidelines |
Important Dates:
|
Watch the video below for updates and answers to frequently asked questions:
Skip ahead in the video and find information on the following topics at these minute markers:
1:30 - Submission deadline | 2:20 - How to submit an abstract | 3:30 - What if I don't have an ISTH membership? | 4:50 - What are the updates to the submission guidelines? | 6:45 - What does a successful abstract look like? | 7:45 - How many tables and figures are allowed? | 8:45 - Can you make edits to your abstract after submission? | 10:10 - When are notifications sent? | 11:45 - How do travel grants work? | 13:10 - Will the ISTH offer poster printing? | 13:45 - Late Breaking Abstract submission changes
1:30 - Submission deadline | 2:20 - How to submit an abstract | 3:30 - What if I don't have an ISTH membership? | 4:50 - What are the updates to the submission guidelines? | 6:45 - What does a successful abstract look like? | 7:45 - How many tables and figures are allowed? | 8:45 - Can you make edits to your abstract after submission? | 10:10 - When are notifications sent? | 11:45 - How do travel grants work? | 13:10 - Will the ISTH offer poster printing? | 13:45 - Late Breaking Abstract submission changes
|
Main Topics:
|
|
The content of the abstract must be related to one of the topics listed below. To ensure smooth scoring of papers, the topic of your work must be selected during the submission process.
|
Arterial Thromboembolism
Atherosclerosis Atrial Fibrillation Cardiovascular Risk Factors Myocardial Infarction Peripheral Vascular Disease Stroke Coagulation and Anticoagulation Animal Models in Thrombosis & Hemostasis Coagulation Factors & Inhibitors Coagulation Proteins beyond Hemostasis Contact Pathway FVIII/IX Hemostasis & Organ Dysfunction Microparticles Protein C Pathway Regulation of Coagulation Tissue Factor Pathway von Willebrand Factor Biology Diagnostics and OMICs Biomarkers of Thrombosis & Hemostasis Blood Components & Management Cellular Therapies Epigenetics, OMICs & Bioinformatics Laboratory Diagnostics Nanotechnology & Novel Biomolecules Fibrinolysis and Proteolysis Fibrinogen & Factor XIII Fibrinolytic Factors & Inhibitors Plasminogen Activation in the CNS and Immunity Proteases & Cancer Thrombolytic Therapy Hemophilia and Bleeding (including Transfusion) Acquired Hemorrhagic Coagulation Disorders Complement & Hemostatic System Disseminated Intravascular Coagulation Hemophilia - Basic Hemophilia - Clinical Hemophilia Gene Therapy Hemostasis & Organ Dysfunction Infection & Hemostatic Factors Management of Bleeding & Trauma Novel Biotherapeutics in Hemophilia Rare Bleeding Disorders VWF & von Willebrand Factor Disorders - Clinical Conditions |
Immunothrombosis and Vascular Biology
Blood Cells & Vessel Wall Endothelial Cell Signaling Inflammation & Sepsis Innate & Adaptive Immunity Non-coding RNAs Protease Activated Receptors Stem Cells & Vascular Cell Growth Nurses Nurses & Allied Health Pediatrics Bleeding in Neonates & Children Thrombosis in Neonates & Children Platelets and Megakaryocytes Megakaryocytes & Thrombopoiesis Platelet Antagonists & Novel Therapeutics Platelet Function & Interactions Platelet Proteomics & Genomics Platelet Receptors Platelet Signaling Platelets & Inflammation Platelets beyond Hemostasis Platelet Disorders Antiplatelet Therapy HIT ITP Platelet Disorders, Hereditary Platelet Disorders, Acquired Platelets, Pediatric Aspects Prothrombotic States ADAMTS13 & TTP Antiphospholipid Syndrome Cancer-Associated Thrombosis HUS & Thrombotic Microangiopathies Venous Thromboembolism DOACs Genetic Risk Factors of Thrombosis Heparins & Heparinoids Novel Anticoagulants Post-thrombotic Syndrome Thrombophilia Vitamin K Antagonists Women's Health Pregnancy & Pregnancy Complications |
How to Submit an Abstract
- Delegates who would like to present their work at the congress, either orally or as a poster, are invited to submit an abstract for consideration by the Scientific Committee.
- ISTH Members and Non-Members are invited to submit abstracts.
- There are no fees to submit an abstract.
- Abstracts can only be submitted online via the abstract submission website that can be found in the section “Abstract Guidelines” on the official ISTH 2019 Congress website. Abstracts sent by post or email will not be accepted. No exceptions will be made.
- The submitter will be required to create a user account in order to submit an abstract. This can be done through the registration system. Once logged in you will be able to select ‘Submit an Abstract’ from the tabs at the top.
- Abstracts can be saved in "Draft” status and be re-edited and modified until the submission deadline (February 4, 2019, 17:00 Eastern Standard Time (U.S.)).
- You can still make edits to abstracts that have been submitted, but you will need to re-submit it before the deadline to be considered.
- The submitted/draft abstracts cannot be edited after the submission deadline.
- Only abstracts that have been submitted properly will be considered for the congress.
- Any technical questions regarding the submission website should be sent to isth2019@abstractserver.com. All other abstract related questions can be sent to abstracts@isth.org.
General Guidelines
- The abstract must address scientific questions, detail clinical observations, or contain primary scientific data.
- Abstracts should be submitted in clear English to allow the reviewers to focus on the scientific content of the abstract. Non-English speaking authors are encouraged to have their abstract checked for grammar and spelling.
- Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proof reading will be done.
- Do not slice results from the same study into multiple abstracts. The Scientific Committee reserves the right to reject abstracts when inappropriate slicing of data is suspected. Similarly, do not submit a copy or close copy of an abstract under more than 1 topic. Abstracts that appear to be submitted multiple times under different topics will be rejected.
- All research and studies in submitted abstracts that involve human subjects or experimental animals must comply with the Declaration of Helsinki.
- No revisions can be made after the abstract deadline.
ISTH Embargo Policy
The media, companies and institutions issuing news releases, and others are required to abide by the embargo policies governing the meeting. The abstracts selected for presentation at ISTH 2019 will be available online two weeks prior to the meeting.
The information contained in the abstracts is embargoed until the abstracts are available online. Coverage of information that goes beyond that which is contained in the four corners of the abstract (e.g., additional analysis, commentary, or updated information from those individuals and companies involved in the study) is embargoed according to the following criteria:
The media, companies and institutions issuing news releases, and others are required to abide by the embargo policies governing the meeting. The abstracts selected for presentation at ISTH 2019 will be available online two weeks prior to the meeting.
The information contained in the abstracts is embargoed until the abstracts are available online. Coverage of information that goes beyond that which is contained in the four corners of the abstract (e.g., additional analysis, commentary, or updated information from those individuals and companies involved in the study) is embargoed according to the following criteria:
- For oral presentations: the embargo time is the start time of the session in which the presentation is being made.
- For poster presentations: the embargo lifts when the poster session containing the poster opens for viewing in the morning (i.e., when the poster hall opens that day).
Preparing an Abstract for Submission
Authors and Co-Authors
Conflict of Interest
Abstract Body
Table and Figures
Prior Publication
Authors and Co-Authors
- The first/presenting author is responsible for ensuring that all authors have read the abstract and agreed to be co-authors.
- The presenting author of the abstract must be registered for the meeting.
- The submission of an abstract constitutes a formal commitment by the submitting (presenting) author to present the abstract (if accepted) in the session and the time assigned by the Scientific Committee. Registration fees will not be waived.
- NEW! A maximum of 20 authors is permitted on each abstract, plus one (1) group.
- Adding Co-authors: please fill out the family names, first names, and institution, city, country and email addresses of each co-authors.
Conflict of Interest
- It is the intent of the ISTH to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting/presenting author of an abstract is requested to declare any potential conflicts of interest for the presenting author during abstract submission.
Abstract Body
- NEW! For standardization, the acceptable length of the abstract is a maximum of 300 words. This does not include the author’s details, titles, tables and figures.
- Title: Clearly indicate the nature of the investigation. The abstract title and text may not contain trade names. The Scientific Committee reserves the right to replace trade names in accepted abstracts.
- Background
- Aims
- Methods: Which should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study
- Results: Which should contain objective data to answer the scientific question(s). A maximum of two total tables or figures may be submitted with this section. Please be sure to number each table and figure and cite each table and figure in the abstract text.
- Conclusion (or Conclusions): Which should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization.
- Other Items for Consideration
- In clinical studies, please state whether informed consent was obtained and whether the study was approved by a recognized medical ethics committee.
- If the research included in your abstract was supported by a pharmaceutical or diagnostics company, you can indicate this when submitting your abstract.
- Please indicate the funding agency of your work if applicable.
- Abbreviations should be defined.
- If off-label use of drugs was involved in the study, please state this clearly.
Table and Figures
- Figures may be submitted with a maximum file size is 10 MB with a resolution of 300 dpi. Figures are allowed in the following formats: PNG, GIF, JPG.
- Tables are allowed with a maximum size of 10 columns x 10 rows. Characters in your table will NOT count towards your 300 word count.
- Tables should be added using the tool in the submitter and not as an image file. Once your table has been created, please remember to drag and drop it into your abstract body.
- Your abstract may contain two (2) graphics. You will be allowed to upload either two (2) figures, two (2) tables, or one (1) figure and one (1) table.
Prior Publication
- NEW! Abstracts submitted to regional or national hematology meetings can be submitted to the ISTH 2019 Congress for inclusion in the program.
- Authors will be permitted to submit their abstract to ISTH 2019 and another journal/meeting as long as the abstract has not been published at the time of submission or will not be published prior to ISTH releasing the abstract (two weeks prior to the meeting).
Late-Breaking Abstracts
- NEW! Late breaking abstracts will not be submitted during the regular abstract submission process. Late breaking abstracts will be submitted following the below timeline:
- Late Breaking Abstract Submission Site Opens: May 24, 2019
- Late Breaking Abstract Submission Site Closes: June 7, 2019
- Congress Dates: July 6 – 10, 2019
- NEW! Late breaking abstracts should highlight novel studies of high impact. Abstracts submitted will be considered as a Late Breaking abstract if the study is ground breaking and includes novel data. The abstract should not have been previously published in any format.
- The late breaking abstract deadline is not intended to be an extension of the regular submission deadline.
- NEW! The review and selection process will be highly competitive. No more than five (5) abstracts will be selected to be featured in one (1) Oral Communication Session. If your abstract is not chosen to be included in the Late Breaking Oral Communication Session, it will be rejected.
- Late Breaking abstracts will not be made available prior to the Congress. The Late Breaking abstracts will be made available at the start of the Late Breaking Oral Communication Session on Monday, July 8.
- All accepted Late Breaking abstracts will be published as an addendum supplement to the ISTH open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH) and are available online here.
Language Setting of Your Keyboard
The keyboard configuration of computers in non-Western countries may cause problems with the printing of the abstracts when special non-Western characters are used. To avoid these problems the language setting of your computer should be changed.
To do this select "Start" then Settings", then "Control Panel" and then choosing "Keyboard." Once in this menu, set the language of your computer to English (United States) or US (International). Next, open MS Word (or the word processing software you are using) and set the font type to Arial.
In the preparation of your abstract, if you require certain special characters that are not available, (e.g. '±', '®', 'μ'), use the insert symbol feature (special characters). To do this, select Arial as the font (unicoded, if possible), then select the required character, and copy and paste the symbol into the text of the abstract. If a special character is still not available, describe the character, e.g. 'alpha’.
The keyboard configuration of computers in non-Western countries may cause problems with the printing of the abstracts when special non-Western characters are used. To avoid these problems the language setting of your computer should be changed.
To do this select "Start" then Settings", then "Control Panel" and then choosing "Keyboard." Once in this menu, set the language of your computer to English (United States) or US (International). Next, open MS Word (or the word processing software you are using) and set the font type to Arial.
In the preparation of your abstract, if you require certain special characters that are not available, (e.g. '±', '®', 'μ'), use the insert symbol feature (special characters). To do this, select Arial as the font (unicoded, if possible), then select the required character, and copy and paste the symbol into the text of the abstract. If a special character is still not available, describe the character, e.g. 'alpha’.
After Submission
An international panel of experts will review the abstracts. Each abstract will be reviewed by 4-6 different experts. Abstracts may be selected for oral presentation, poster presentation, publication only or rejection. The first author will be notified in early-April 2019, at the email address provided during submission, about whether or not their abstract has been accepted.
The reviewers will judge the abstracts according to the following criteria:
Please note:
An international panel of experts will review the abstracts. Each abstract will be reviewed by 4-6 different experts. Abstracts may be selected for oral presentation, poster presentation, publication only or rejection. The first author will be notified in early-April 2019, at the email address provided during submission, about whether or not their abstract has been accepted.
The reviewers will judge the abstracts according to the following criteria:
- Is the abstract original?
- Does it address an important scientific question?
- Is the abstract clearly written with all salient facts?
- Does the work adhere to ethical guidelines?
- Is there evidence of statistical method if appropriate?
- Are the conclusions justified by the results?
Please note:
- No revisions can be made after the abstract deadline.
- NEW! The review and selection process for Late Breaking Abstracts will be highly competitive. No more than five (5) abstracts will be selected to be featured in one (1) Oral Communication Session. If your abstract is not chosen to be included in the Late Breaking Oral Communication Session, it will be rejected. Late Breaking Abstract Submission will open on May 24, 2019
- The best scoring abstracts will be selected for oral presentation.
- Oral Presentation: Authors of abstracts selected for oral presentation will be informed about the date and time of the session. Presentation guidelines will be made available online.
- Poster Presentation: Poster presenters will be informed about the date and time of the poster exhibition. Poster guidelines will be made available online. Posters will be organized within the session using the topics chosen by the submitter in the online system.
- All accepted abstracts will be published online only as an addendum supplement to the ISTH open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH) and will be made available on the ISTH 2019 Congress website two weeks prior to the Congress.
Withdrawal Policy
If authors wish to withdraw their abstracts from presentation or publication they are requested to notify ISTH via e-mail to abstracts@isth.org before May 8, 2019. Withdrawn abstracts will not be presented nor will these be published.
If authors wish to withdraw their abstracts from presentation or publication they are requested to notify ISTH via e-mail to abstracts@isth.org before May 8, 2019. Withdrawn abstracts will not be presented nor will these be published.
Travel Grants
The ISTH offers two different awards that are provided in the form of travel grants. The Early Career Award and Reach-the-World Award are available to those who are first authors on an abstract. Click here to learn more.
The ISTH offers two different awards that are provided in the form of travel grants. The Early Career Award and Reach-the-World Award are available to those who are first authors on an abstract. Click here to learn more.
Technical Requirements
The online abstract submission system works best with Internet Explorer 7.0 or higher or Mozilla Firefox 3.0 or higher. Cookies and JavaScript need to be enabled.
The online abstract submission system works best with Internet Explorer 7.0 or higher or Mozilla Firefox 3.0 or higher. Cookies and JavaScript need to be enabled.